| |
|
|
|
DiaMedica Therapeutics Inc.  
|
|
3.3 -0.17 (-0.05%) |
11-21 14:58 |
|
Open: |
3.34 |
Pre close: |
3.47 |
Target:
|
4.50
|
|
High: |
3.4599 |
Low: |
3.17 |
Resistance:
|
3.85
4.50
|
|
Volume: |
22,863 |
Market Cap: |
40M |
Support:
|
3.07
 2.58
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.56
|
MACD |
MACD(12,26):
|
0.25  |
|
MA(20): |
3.15 |
Signal(12,26,9): |
0.22 |
|
MA(100): |
3.02 |
Stochastic Oscillator |
%K(14,3):
|
71.73 |
|
MA(250): |
3.36 |
%D(3): |
79.19 |
|
Average Volume(K) |
3-Month: |
4039
|
52-Week |
High:
|
6.53 |
|
10-Days: |
4539 |
Low: |
1.70 |
|
RSI |
RSI(14):
|
59.10 |
Change(%): |
-16.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.983 |
Return on Equity (ttm) |
-199.0 |
Shares Out. (M) |
12.01 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-80.9 |
Shares Float (M) |
9.12 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.37 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
13.72 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.042 |
Shares Short (K) |
4 |
|
Book Value (p.s.) |
0.810 |
EBITDA (p.s.) |
-0.885 |
P/E |
-3.50 |
|
Sales Per Share |
-0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.25 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-9.12 |
P/S |
0.00 |
|
Operating Margin |
291186.75 |
Levered Free Cash Flow
(M) |
-6.60 |
P/CF |
-4.53 |
|
|
|
|
|
|
